Monitoring
Long-term monitoring of AL amyloidosis involves serialised measurements of serum immunoglobulin free light chain, repeated serum and urine immunofixation electrophoresis, serum creatinine, and 24-hour total urinary protein.
Echocardiogram should be repeated every 6 months.
Serialised measurements of serum troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are useful in assessing the status of the heart, with rising levels indicating worsening cardiac status.
Use of this content is subject to our disclaimer